XGN News and Press, Exagen Inc. From 05/08/25

CARLSBAD, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3,350,000 shares of its common stock at a public offering price of $5.25 p...

2025-05-05 16:52:35 ET More on Exagen Exagen Inc. (XGN) Q1 2025 Earnings Call Transcript Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability Exagen Inc. (XGN) Q4 2024 Earnings Call Transcript Exagen announces senior secured c...

2025-05-05 16:51:40 ET Exagen Inc. (XGN) Q1 2025 Earnings Conference Call May 05, 2025 08:30 AM ET Company Participants Ryan Douglas - Investor Relations John Aballi - President & Chief Executive Officer Jeff Black - Chief Financial Officer Conference C...

2025-05-05 10:20:01 ET More on Industrial Select Sector SPDR® Fund ETF, Health Care Select Sector SPDR® Fund ETF, etc. Read the full article on Seeking Alpha For further details see: These are the sectors best liked within defensive and cyclicals groups – Mo...

2025-05-05 08:03:01 ET More on Exagen Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability Exagen Inc. (XGN) Q4 2024 Earnings Call Transcript Exagen announces senior secured credit facility Seeking Alpha’s Quant Rating ...

CARLSBAD, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2025, and recent corporate updates. Q1 2025 Highlights and Recent Corporate Updates ...

National Health Investors Inc. (NHI) is expected to report $1.13 for Q1 2025 Palomar Holdings Inc. (PLMR) is expected to report $1.45 for Q1 2025 Weave Communications Inc. (WEAV) is expected to report $-0.11 for Q1 2025 First National Bank Alaska (FBAK) is expected to report for Q1 20...

2025-04-29 10:36:00 ET Shares of Exagen Inc. (NASDAQ: XGN) traded at a new 52-week high today and are currently trading at $6.35. So far today, approximately 122.64k shares have been exchanged, as compared to an average 30-day volume of 119.57k shares. Exagen Inc. develops and comme...

2025-04-28 11:09:47 ET Shares of Exagen Inc. (NASDAQ: XGN) traded at a new 52-week high today and are currently trading at $6.43. So far today, approximately 64,381 shares have been exchanged, as compared to an average 30-day volume of 113.99k shares. Exagen Inc. develops and commer...

2025-04-28 09:19:20 ET More on Exagen Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability Exagen Inc. (XGN) Q4 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Exagen Historical earnings data for Exagen ...